Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Drug Resistance

Free Subscription Articles published in AIDS Retrieve available abstracts of 20 articles: HTML format Text format

Single Articles

December 2017
1. NEOGI U, Singh K, Aralaguppe SG, Rogers LC, et al
   Ex vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV-1 non-B subtypes.
   AIDS. 2017 Dec 12. doi: 10.1097/QAD.0000000000001726.
   PubMed     Text format     Abstract available
   
   
   November 2017
2. LODI S, Gunthard HF, Dunn D, Garcia F, et al
   Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance.
   AIDS. 2017 Nov 10. doi: 10.1097/QAD.0000000000001692.
   PubMed     Text format     Abstract available
   
   
   
3. OLSON A, Bannert N, Sonnerborg A, de Mendoza C, et al
   Temporal trends of transmitted HIV drug resistance in a multinational seroconversion cohort.
   AIDS. 2017 Nov 2. doi: 10.1097/QAD.0000000000001689.
   PubMed     Text format     Abstract available
   
   
   October 2017
4. MENZA TW, Billock R, Samoff E, Eron JJ, et al
   Pretreatment integrase strand transfer inhibitor resistance in North Carolina from 2010-2016.
   AIDS. 2017;31:2235-2244.
   PubMed     Text format     Abstract available
   
   
   
5. TARTAGLIA A, Ferrara SM, Sica S, Santantonio T, et al
   Successful treatment with tenofovir alafenamide of a HIV/hepatitis B virus coinfected patient with HIV and hepatitis B virus drug resistance, end-stage renal disease on haemodialysis.
   AIDS. 2017;31:2314-2315.
   PubMed     Text format    
   
   
   August 2017
6. POPPE LK, Chunda-Liyoka C, Kwon EH, Gondwe C, et al
   HIV drug resistance in infants increases with changing prevention of mother-to-child transmission regimens.
   AIDS. 2017;31:1885-1889.
   PubMed     Text format     Abstract available
   
   
   June 2017
7. GATANAGA H, Brumme ZL, Adland E, Reyes-Teran G, et al
   Potential for immune-driven viral polymorphisms to compromise antiretroviral-based pre-exposure prophylaxis for prevention of HIV-1 infection.
   AIDS. 2017 Jun 23. doi: 10.1097/QAD.0000000000001575.
   PubMed     Text format     Abstract available
   
   
   April 2017
8. INZAULE SC, Hamers RL, Mukui I, Were K, et al
   Emergence of untreatable, multidrug-resistant HIV-1 in patients failing second-line therapy in Kenya.
   AIDS. 2017 Apr 10. doi: 10.1097/QAD.0000000000001500.
   PubMed     Text format     Abstract available
   
   
   
9. LEPIK KJ, Harrigan PR, Yip B, Wang L, et al
   Emergent drug resistance with integrase strand transfer inhibitor-based regimens: Incidence and risk factors.
   AIDS. 2017 Apr 3. doi: 10.1097/QAD.0000000000001494.
   PubMed     Text format     Abstract available
   
   
   March 2017
10. KANTHULA R, Rossouw T, Feucht UD, Van Dyk G, et al
    Persistence of HIV-drug-resistance among South African Children given Nevirapine to Prevent Mother-to-Child-Transmission.
    AIDS. 2017 Mar 15. doi: 10.1097/QAD.0000000000001446.
    PubMed     Text format     Abstract available
    
    
    January 2017
11. NEWSUM AM, Ho CK, Lieveld FI, van de Laar TJ, et al
    The hepatitis C virus nonstructural protein 3 Q80K polymorphism is frequently detected and transmitted among HIV-infected MSM in the Netherlands.
    AIDS. 2017;31:105-112.
    PubMed     Text format     Abstract available
    
    
    November 2016
12. KUNKEL A, Crawford FW, Shepherd J, Cohen T, et al
    Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.
    AIDS. 2016;30:2715-2723.
    PubMed     Text format     Abstract available
    
    
    
13. BRENNER B, Wainberg MA
    We need to use the best antiretroviral drugs worldwide to prevent HIV drug resistance.
    AIDS. 2016;30:2725-2727.
    PubMed     Text format    
    
    
    September 2016
14. MURI L, Gamell A, Ntamatungiro AJ, Glass TR, et al
    Development of HIV drug resistance and therapeutic failure in children and adolescents in rural tanzania - an emerging public health concern.
    AIDS. 2016.
    PubMed     Text format     Abstract available
    
    
    
15. VILLABONA-ARENAS CJ, Vidal N, Guichet E, Serrano L, et al
    In-depth analysis of HIV-1 drug resistance mutations in HIV-infected individuals failing first-line regimens in West and Central Africa.
    AIDS. 2016.
    PubMed     Text format     Abstract available
    
    
    June 2016
16. OLIVEIRA M, Ibanescu RI, Pham HT, Brenner B, et al
    The M184I/V and K65R nucleoside resistance mutations in HIV-1 prevent the emergence of resistance mutations against dolutegravir.
    AIDS. 2016.
    PubMed     Text format     Abstract available
    
    
    
17. HARPER K
    The emergence of acquired HIV-1 drug resistance has almost been stopped in Switzerland.
    AIDS. 2016.
    PubMed     Text format    
    
    
    
18. DUARTE F, Miranda AC, Peres S, Diogo I, et al
    Transmitted drug resistance in drug-naive HIV-2 infected patients.
    AIDS. 2016;30:1687-8.
    PubMed     Text format    
    
    
    April 2016
19. MUSIIME V, Kasirye P, Naidoo-James B, Nahirya-Ntege P, et al
    Once versus twice daily abacavir and lamivudine in African children: The randomised controlled ARROW Trial.
    AIDS. 2016.
    PubMed     Text format     Abstract available
    
    
    
20. CHUNG MH, Silverman R, Beck IA, Yatich N, et al
    Increasing HIV-1 pre-treatment drug resistance among antiretroviral-naive adults initiating treatment between 2006 and 2014 in Nairobi, Kenya.
    AIDS. 2016.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: